NM_000546.6(TP53):c.422G>A (p.Cys141Tyr) AND Li-Fraumeni syndrome 1

Germline classification:: Pathogenic/Likely pathogenic (2 submissions)
Last evaluated:: Feb 13, 2024
Review status:: 2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002288619.3

Allele description [Variation Report for NM_000546.6(TP53):c.422G>A (p.Cys141Tyr)]

NM_000546.6(TP53):c.422G>A (p.Cys141Tyr)

Gene:

TP53:tumor protein p53 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

17p13.1

Genomic location:

Preferred name:

NM_000546.6(TP53):c.422G>A (p.Cys141Tyr)

HGVS:

NC_000017.11:g.7675190C>T
NG_017013.2:g.17361G>A
NM_000546.6:c.422G>AMANE SELECT
NM_001126112.3:c.422G>A
NM_001126113.3:c.422G>A
NM_001126114.3:c.422G>A
NM_001126115.2:c.26G>A
NM_001126116.2:c.26G>A
NM_001126117.2:c.26G>A
NM_001126118.2:c.305G>A
NM_001276695.3:c.305G>A
NM_001276696.3:c.305G>A
NM_001276697.3:c.-56G>A
NM_001276698.3:c.-56G>A
NM_001276699.3:c.-56G>A
NM_001276760.3:c.305G>A
NM_001276761.3:c.305G>A
NP_000537.3:p.Cys141Tyr
NP_000537.3:p.Cys141Tyr
NP_001119584.1:p.Cys141Tyr
NP_001119585.1:p.Cys141Tyr
NP_001119586.1:p.Cys141Tyr
NP_001119587.1:p.Cys9Tyr
NP_001119588.1:p.Cys9Tyr
NP_001119589.1:p.Cys9Tyr
NP_001119590.1:p.Cys102Tyr
NP_001263624.1:p.Cys102Tyr
NP_001263625.1:p.Cys102Tyr
NP_001263689.1:p.Cys102Tyr
NP_001263690.1:p.Cys102Tyr
LRG_321t1:c.422G>A
LRG_321:g.17361G>A
LRG_321p1:p.Cys141Tyr
NC_000017.10:g.7578508C>T
NM_000546.4:c.422G>A
NM_000546.5:c.422G>A
P04637:p.Cys141Tyr
p.C141Y

Protein change:

C102Y

Links:

UniProtKB: P04637#VAR_005886; dbSNP: rs587781288

NCBI 1000 Genomes Browser:

rs587781288

Molecular consequence:

NM_001276697.3:c.-56G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001276698.3:c.-56G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001276699.3:c.-56G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000546.6:c.422G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126112.3:c.422G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126113.3:c.422G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126114.3:c.422G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126115.2:c.26G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126116.2:c.26G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126117.2:c.26G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001126118.2:c.305G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001276695.3:c.305G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001276696.3:c.305G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001276760.3:c.305G>A - missense variant - [Sequence Ontology: SO:0001583]
NM_001276761.3:c.305G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Li-Fraumeni syndrome 1 (LFS)
Identifiers:: Gene: 553989; MedGen: C1835398; Orphanet: 524; OMIM: 151623

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002583165	Genome-Nilou Lab	criteria provided, single submitter (ACMG Guidelines, 2015)	Pathogenic (Jun 18, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]
SCV004930458	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Likely pathogenic (Feb 13, 2024)	unknown	clinical testing	PubMed (4) [See all records that cite these PMIDs] 8816796, 9418900, 11370630, 20522432 Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002583165

Genome-Nilou Lab

criteria provided, single submitter

(ACMG Guidelines, 2015)

Pathogenic
(Jun 18, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004930458

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Likely pathogenic
(Feb 13, 2024)

unknown

clinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing
not provided	germline	no	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

PMID:: 25741868
PMCID:: PMC4544753

Use of genetic suppressor elements to dissect distinct biological effects of separate p53 domains.

Ossovskaya VS, Mazo IA, Chernov MV, Chernova OB, Strezoska Z, Kondratov R, Stark GR, Chumakov PM, Gudkov AV.

Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10309-14.

PubMed [citation]

PMID:: 8816796
PMCID:: PMC38380

See all PubMed Citations (5)

Details of each submission

From Genome-Nilou Lab, SCV002583165.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	no	not provided	not provided	not provided		not provided	not provided	not provided	not provided

From Myriad Genetics, Inc., SCV004930458.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (4)

Description

This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 8816796, 9418900]. This variant is expected to disrupt protein structure [Myriad internal data]. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 11370630, 20522432].

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 16, 2025

ClinVar

Relating variation to medicine